Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital

Pharmacy World and Science

Volumn 25, Issue 6, 2003, Pages 299-302

  Zaidi, Syed Tabish Razi ^a   Hassan, Yahaya ^b   Postma, Maarten J ^c   Ng, Seiw Hain ^d  

^a King Abdul Aziz Hospital   (Saudi Arabia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d HOSPITAL RAJA PERMAISURI BAINUN   (Malaysia)

Author keywords

Cost saving; Drug therapy; Drug related problems; Intensive care unit; Interventions; Malaysia; Pharmacist; Pharmacist recommendations

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIULCER AGENT; ANTIVIRUS AGENT;

COST CONTROL; DECISION MAKING; DRUG COST; HOSPITAL PHARMACY; INTENSIVE CARE UNIT; MALAYSIA; PHARMACEUTICAL CARE; PHARMACIST; REVIEW;

COST SAVINGS; DRUG UTILIZATION REVIEW; HUMANS; INTENSIVE CARE UNITS; MALAYSIA; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE;

EID: 0345095315     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAR.0000006524.52076.2f     Document Type: Review

References (10)

1. Ellinoy BR, Clarke JE, Wagers PW and Swinney RS, Comprehensive pharmaceutical services in a medical intensive-care unit. Am J Hosp Pharm. 1984; 41: 2335-42.
2. Chuang LC, Sutton JD and Henderson GT, Impact of a clinical pharmacist on the cost saving and cost avoidance in drug therapy in an intensive care unit. Hosp Pharm 1994; 29: 215-8, 221.
3. Leape LL, Cullen DJ, Clapp MD, Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282: 267-70.
4. Montazeri M, Cook DJ. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 1994; 22: 1044-8.
5. Miyagawa CI, Rivera JO, Effect of pharmacist intervention on drug therapy costs in a surgical intensive care unit. Am J Hosp Pharm 1986; 43: 3008-13.
6. Task Force on Position Paper on Critical Care Pharmacy Service, Socirty of Critic Care Med and American College of Clin Pharm. Position paper on critical care pharmacy Services. Pharmacotherapy. 2000; 20(11): 1400-6.
7. Hassan Y, Aziz NA, Awang J, and Aminuddin AG, An analysis of clinical pharmacist interventions in an intensive care unit. J Clin Pharm and Ther 1992; 17: 347-51.
8. Willet MS, Bertch KE, Rich DS. Prospectus on the economic value of clinical pharmacy services - a position statement of American College Of Clinical Pharmacy. Pharmacotherapy 1989; 9: 45-56.
9. Richardson LP, Wiseman SW, Malani PN, Lyons MJ, Kauffman CA. Effectiveness of a vancomycin restriction policy in changing the prescribing pattern. Microb Drug Resist 2000; 6(4): 327-30.
10. Tschida SJ, Hoey LL, Vance-Bryan K. The impact of practice guidelines on prescribing patterns of nondeplorizing neuromascular blocking agents. Pharmacotherapy 1996; 16(5): 899-904.